Sherie L. Morrison - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology, Immunology, Microbiology Biology

214 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Xu S, Zhou T, Doh HM, Trinh KR, Catapang A, Lee JT, Braas D, Bayley NA, Yamada RE, Vasuthasawat A, Sasine JP, Timmerman JM, Larson SM, Kim Y, Macleod AR, ... Morrison SL, et al. An HK2 antisense oligonucleotide induces synthetic lethality in HK1-HK2+ multiple myeloma. Cancer Research. PMID 30885978 DOI: 10.1158/0008-5472.Can-18-2799  0.64
2018 Young PA, Yamada RE, Trinh KR, Vasuthasawat A, De Oliveira S, Yamada DH, Morrison SL, Timmerman JM. Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 38: 239-254. PMID 29920129 DOI: 10.1089/Jir.2018.0030  0.64
2017 Li Z, Zhu Y, Li C, Trinh R, Ren X, Sun F, Wang Y, Shang P, Wang T, Wang M, Morrison SL, Zhang J. Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer. Oncoimmunology. 6: e1290038. PMID 28405526 DOI: 10.1080/2162402X.2017.1290038  0.36
2016 Vasuthasawat A, Yoo EM, Trinh KR, Lichtenstein A, Timmerman JM, Morrison SL. Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma. Mabs. 0. PMID 27362935 DOI: 10.1080/19420862.2016.1207030  0.32
2015 Yamada DH, Elsaesser H, Lux A, Timmerman JM, Morrison SL, de la Torre JC, Nimmerjahn F, Brooks DG. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. Immunity. 42: 379-90. PMID 25680277 DOI: 10.1016/J.Immuni.2015.01.005  0.32
2015 Valenzuela NM, Trinh KR, Mulder A, Morrison SL, Reed EF. Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1502-18. PMID 25648976 DOI: 10.1111/Ajt.13174  0.48
2015 Yoo EM, Trinh KR, Tran D, Vasuthasawat A, Zhang J, Hoang B, Lichtenstein A, Morrison SL. Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 281-91. PMID 25353626 DOI: 10.1089/Jir.2014.0125  1
2015 Payés CJ, Daniels‐Wells TR, Maffía PC, Penichet ML, Morrison SL, Helguera G. Genetic Engineering of Antibody Molecules Reviews in Cell Biology and Molecular Medicine. 1: 1-52. DOI: 10.1002/3527600906.Mcb.200200007.Pub2  1
2014 Young PA, Morrison SL, Timmerman JM. Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety. Seminars in Oncology. 41: 623-36. PMID 25440607 DOI: 10.1053/J.Seminoncol.2014.08.002  0.32
2014 Morrison SL, Yoo EM. Genetically Engineered Antibody Molecules Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.00129-X  1
2013 Trinh KR, Vasuthasawat A, Steward KK, Yamada RE, Timmerman JM, Morrison SL. Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 305-18. PMID 23719241 DOI: 10.1097/Cji.0B013E3182993Eb9  0.64
2013 Asai T, Morrison SL. The SRC family tyrosine kinase HCK and the ETS family transcription factors SPIB and EHF regulate transcytosis across a human follicle-associated epithelium model. The Journal of Biological Chemistry. 288: 10395-405. PMID 23439650 DOI: 10.1074/Jbc.M112.437475  1
2013 De Oliveira SN, Wang J, Ryan C, Morrison SL, Kohn DB, Hollis RP. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors. Journal of Translational Medicine. 11: 23. PMID 23360526 DOI: 10.1186/1479-5876-11-23  1
2011 Ngarmchamnanrith G, Yamada RE, Steward KK, Khare S, Sachdev R, Morrison SL, Timmerman J. Activity of anti-CD20-interferon-α fusion protein against human B-cell lymphomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8047. PMID 28023567 DOI: 10.1200/Jco.2011.29.15_Suppl.8047  0.32
2011 Kim S, Kim YC, Qi H, Su K, Morrison SL, Chow SA. Efficient identification of human immunodeficiency virus type 1 mutants resistant to a protease inhibitor by using a random mutant library. Antimicrobial Agents and Chemotherapy. 55: 5090-8. PMID 21876045 DOI: 10.1128/Aac.00687-11  1
2011 Mershon-Shier KL, Vasuthasawat A, Takahashi K, Morrison SL, Beenhouwer DO. In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways. Molecular Immunology. 48: 2009-18. PMID 21723612 DOI: 10.1016/J.Molimm.2011.06.215  0.64
2011 Yoo EM, Trinh KR, Lim H, Wims LA, Morrison SL. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor. Molecular Immunology. 48: 1818-26. PMID 21632111 DOI: 10.1016/J.Molimm.2011.05.011  1
2010 Yoo EM, Yu LJ, Wims LA, Goldberg D, Morrison SL. Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. Mabs. 2: 320-34. PMID 20431350 DOI: 10.4161/Mabs.2.3.11802  1
2010 Xuan C, Steward KK, Timmerman JM, Morrison SL. Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma. Blood. 115: 2864-71. PMID 20139095 DOI: 10.1182/Blood-2009-10-250555  1
2009 Afshar S, Olafsen T, Wu AM, Morrison SL. Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT. Journal of Experimental & Clinical Cancer Research : Cr. 28: 147. PMID 19958550 DOI: 10.1186/1756-9966-28-147  1
2009 Kim YC, Morrison SL. A rapid and economic in-house DNA purification method using glass syringe filters. Plos One. 4: e7750. PMID 19924285 DOI: 10.1371/Journal.Pone.0007750  1
2009 Cho JS, Kim YC, Morrison SL. Inhibitors of MyD88-dependent proinflammatory cytokine production identified utilizing a novel RNA interference screening approach. Plos One. 4: e7029. PMID 19753301 DOI: 10.1371/Journal.Pone.0007029  1
2009 Kim YC, Lee HS, Yoon S, Morrison SL. Transposon-directed base-exchange mutagenesis (TDEM): a novel method for multiple-nucleotide substitutions within a target gene. Biotechniques. 46: 534-42. PMID 19594453 DOI: 10.2144/000113152  1
2009 Afshar S, Sawaya MR, Morrison SL. Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine. Protein Science : a Publication of the Protein Society. 18: 1107-14. PMID 19388075 DOI: 10.1002/Pro.91  1
2009 Afshar S, Asai T, Morrison SL. Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer. Molecular Cancer Therapeutics. 8: 185-93. PMID 19139128 DOI: 10.1158/1535-7163.Mct-08-0652  1
2009 Mershon KL, Vasuthasawat A, Lawson GW, Morrison SL, Beenhouwer DO. Role of complement in protection against Cryptococcus gattii infection. Infection and Immunity. 77: 1061-70. PMID 19114546 DOI: 10.1128/Iai.01119-08  1
2009 Kim YC, Morrison SL. N-terminal domain-deleted mu transposase exhibits increased transposition activity with low target site preference in modified buffers. Journal of Molecular Microbiology and Biotechnology. 17: 30-40. PMID 19033677 DOI: 10.1159/000178019  1
2009 Cho JS, Hsu JV, Morrison SL. Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity. Cancer Immunology, Immunotherapy : Cii. 58: 1057-69. PMID 19018533 DOI: 10.1007/S00262-008-0622-2  1
2009 Montano RF, Penichet ML, Blackall DP, Morrison SL, Chintalacharuvu KR. Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents. Journal of Immunological Methods. 340: 1-10. PMID 18848836 DOI: 10.1016/J.Jim.2008.09.011  1
2009 Mershon KL, Morrison SL. Antibody-Complement Interaction Therapeutic Monoclonal Antibodies: From Bench to Clinic. 371-383. DOI: 10.1002/9780470485408.ch16  1
2008 Cheng LS, Hwang S, Huang TH, Sheu TC, Sun R, Morrison SL, Cheng G, Shahangian A. Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons. Cell Research. 18: 1230-2. PMID 19002159 DOI: 10.1038/Cr.2008.304  1
2008 Aslam A, Quinn P, McIntosh RS, Shi J, Ghumra A, McKerrow JH, Bunting KA, Dunne DW, Doenhoff MJ, Morrison SL, Zhang K, Pleass RJ. Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions. Molecular Immunology. 45: 567-74. PMID 17631966 DOI: 10.1016/J.Molimm.2007.05.021  1
2007 Morrison SL. Two heads are better than one. Nature Biotechnology. 25: 1233-4. PMID 17989683 DOI: 10.1038/Nbt1107-1233  1
2007 Huang TH, Chintalacharuvu KR, Morrison SL. Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities. Journal of Immunology (Baltimore, Md. : 1950). 179: 6881-8. PMID 17982079 DOI: 10.4049/Jimmunol.179.10.6881  1
2007 Chintalacharuvu KR, Gurbaxani B, Morrison SL. Incomplete assembly of IgA2m(2) in Chinese hamster ovary cells. Molecular Immunology. 44: 3445-52. PMID 17467056 DOI: 10.1016/J.Molimm.2006.12.030  1
2007 Olafsen T, Gu Z, Sherman MA, Leyton JV, Witkosky ME, Shively JE, Raubitschek AA, Morrison SL, Wu AM, Reiter RE. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 396-405. PMID 17457214 DOI: 10.1097/Cji.0B013E318031B53B  1
2007 Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infection and Immunity. 75: 1424-35. PMID 17220317 DOI: 10.1128/Iai.01161-06  1
2007 Yoo EM, Chintalacharuvu KR, Morrison SL. Recombinant IgA antibodies Mucosal Immune Defense: Immunoglobulin A. 390-415. DOI: 10.1007/978-0-387-72232-0_15  1
2006 Ng PP, Helguera G, Daniels TR, Lomas SZ, Rodriguez JA, Schiller G, Bonavida B, Morrison SL, Penichet ML. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood. 108: 2745-54. PMID 16804109 DOI: 10.1182/Blood-2006-04-020263  1
2006 Huang TH, Morrison SL. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia. The Journal of Pharmacology and Experimental Therapeutics. 316: 983-91. PMID 16291729 DOI: 10.1124/Jpet.105.095513  1
2006 Gurbaxani BM, Morrison SL. Development of new models for the analysis of Fc-FcRn interactions. Molecular Immunology. 43: 1379-89. PMID 16183124 DOI: 10.1016/J.Molimm.2005.08.002  1
2006 Gurbaxani B, Dela Cruz LL, Chintalacharuvu K, Morrison SL. Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life. Molecular Immunology. 43: 1462-73. PMID 16139891 DOI: 10.1016/J.Molimm.2005.07.032  1
2006 Helguera G, Dela Cruz JS, Lowe C, Ng PP, Trinh R, Morrison SL, Penichet ML. Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors. Vaccine. 24: 304-16. PMID 16125282 DOI: 10.1016/J.Vaccine.2005.07.073  1
2006 Dela Cruz JS, Trinh KR, Chen HW, Ribas A, Morrison SL, Penichet ML. Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies. Molecular Immunology. 43: 667-76. PMID 15908002 DOI: 10.1016/J.Molimm.2005.04.007  1
2006 Penichet ML, Morrison SL. Antibody Molecules, Genetic Engineering of Reviews in Cell Biology and Molecular Medicine. DOI: 10.1002/3527600906.Mcb.200200007  1
2005 Zhu L, van de Lavoir MC, Albanese J, Beenhouwer DO, Cardarelli PM, Cuison S, Deng DF, Deshpande S, Diamond JH, Green L, Halk EL, Heyer BS, Kay RM, Kerchner A, Leighton PA, ... ... Morrison SL, et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nature Biotechnology. 23: 1159-69. PMID 16127450 DOI: 10.1038/Nbt1132  1
2005 Dela Cruz JS, Morrison SL, Penichet ML. Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein. Vaccine. 23: 4793-803. PMID 15967544 DOI: 10.1016/J.Vaccine.2005.04.041  1
2005 Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe ML, Morrison SL, Penichet ML, Kwon YG, Kim TW, Webster KA, Nechustan H, Shin SU. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein. Molecular Cancer Therapeutics. 4: 956-67. PMID 15956253 DOI: 10.1158/1535-7163.Mct-04-0321  1
2005 Yoo EM, Morrison SL. IgA: an immune glycoprotein. Clinical Immunology (Orlando, Fla.). 116: 3-10. PMID 15925826 DOI: 10.1016/J.Clim.2005.03.010  1
2005 Asai T, Wims LA, Morrison SL. An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery. Journal of Immunological Methods. 299: 63-76. PMID 15914191 DOI: 10.1016/J.Jim.2005.01.020  1
2005 Asai T, Trinh R, Ng PP, Penichet ML, Wims LA, Morrison SL. A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery. Biomolecular Engineering. 21: 145-55. PMID 15748688 DOI: 10.1016/J.Bioeng.2004.10.001  1
2004 Dela Cruz JS, Huang TH, Penichet ML, Morrison SL. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer. Clinical and Experimental Medicine. 4: 57-64. PMID 15672942 DOI: 10.1007/S10238-004-0039-Y  1
2004 Chan LA, Phillips ML, Wims LA, Trinh KR, Denham J, Morrison SL. Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions. Molecular Immunology. 41: 527-38. PMID 15183931 DOI: 10.1016/J.Molimm.2004.03.034  0.52
2004 Gala FA, Morrison SL. V region carbohydrate and antibody expression. Journal of Immunology (Baltimore, Md. : 1950). 172: 5489-94. PMID 15100290 DOI: 10.4049/Jimmunol.172.9.5489  1
2004 Trinh R, Gurbaxani B, Morrison SL, Seyfzadeh M. Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression. Molecular Immunology. 40: 717-22. PMID 14644097 DOI: 10.1016/J.Molimm.2003.08.006  1
2004 Penichet ML, Morrison SL. Design and engineering human forms of monoclonal antibodies Drug Development Research. 61: 121-136. DOI: 10.1002/Ddr.10347  1
2003 Chintalacharuvu KR, Chuang PD, Dragoman A, Fernandez CZ, Qiu J, Plaut AG, Trinh KR, Gala FA, Morrison SL. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infection and Immunity. 71: 2563-70. PMID 12704129 DOI: 10.1128/Iai.71.5.2563-2570.2003  1
2003 Yoo EM, Wims LA, Chan LA, Morrison SL. Human IgG2 can form covalent dimers. Journal of Immunology (Baltimore, Md. : 1950). 170: 3134-8. PMID 12626570 DOI: 10.4049/Jimmunol.170.6.3134  1
2003 Dela Cruz JS, Lau SY, Ramirez EM, De Giovanni C, Forni G, Morrison SL, Penichet ML. Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice. Vaccine. 21: 1317-26. PMID 12615426 DOI: 10.1016/S0264-410X(02)00741-7  1
2002 Morrison SL. Cloning, expression, and modification of antibody V regions. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 2.12. PMID 18432877 DOI: 10.1002/0471142735.Im0212S47  1
2002 Helguera G, Morrison SL, Penichet ML. Antibody-cytokine fusion proteins: Harnessing the combined power of cytokines and antibodies for cancer therapy Clinical Immunology. 105: 233-246. PMID 12498805 DOI: 10.1006/Clim.2002.5302  1
2002 Chintalacharuvu KR, Yu LJ, Bhola N, Kobayashi K, Fernandez CZ, Morrison SL. Cysteine residues required for the attachment of the light chain in human IgA2. Journal of Immunology (Baltimore, Md. : 1950). 169: 5072-7. PMID 12391223 DOI: 10.4049/Jimmunol.169.9.5072  0.64
2002 Ng PP, Dela Cruz JS, Sorour DN, Stinebaugh JM, Shin SU, Shin DS, Morrison SL, Penichet ML. An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 10706-11. PMID 12149472 DOI: 10.1073/Pnas.162362999  1
2002 Gala FA, Morrison SL. The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. The Journal of Biological Chemistry. 277: 29005-11. PMID 12023968 DOI: 10.1074/Jbc.M203258200  1
2002 Yoo EM, Chintalacharuvu KR, Penichet ML, Morrison SL. Myeloma expression systems. Journal of Immunological Methods. 261: 1-20. PMID 11861062 DOI: 10.1016/S0022-1759(01)00559-2  1
2002 Morrison SL, Mohammed MS, Wims LA, Trinh R, Etches R. Sequences in antibody molecules important for receptor-mediated transport into the chicken egg yolk. Molecular Immunology. 38: 619-25. PMID 11792430 DOI: 10.1016/S0161-5890(01)00095-5  1
2002 Westin Kwon K, Lendvai N, Morrison S, Trinh KR, Casadevall A. Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide. Clinical and Diagnostic Laboratory Immunology. 9: 201-4. PMID 11777857 DOI: 10.1128/Cdli.9.1.201-204.2002  1
2002 Montaño RF, Morrison SL. Influence of the isotype of the light chain on the properties of IgG. Journal of Immunology (Baltimore, Md. : 1950). 168: 224-31. PMID 11751966 DOI: 10.4049/Jimmunol.168.1.224  1
2001 Morrison SL. Double-stranded DNA sequence analysis Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432690 DOI: 10.1002/0471142735.Im1025S14  1
2001 Morrison SL. Transfection of lymphoid cells Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432681 DOI: 10.1002/0471142735.Im1017Bs31  1
2001 Morrison SL. Transformation of E. coli by electroporation Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432665 DOI: 10.1002/0471142735.Ima03Ns21  1
2001 Morrison SL. Preparing frozen bacterial stocks Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432664 DOI: 10.1002/0471142735.Ima03Ms21  1
2001 Chintalacharuvu KR, Vuong LU, Loi LA, Larrick JW, Morrison SL. Hybrid IgA2/IgG1 antibodies with tailor-made effector functions. Clinical Immunology (Orlando, Fla.). 101: 21-31. PMID 11580223 DOI: 10.1006/Clim.2001.5083  0.64
2001 Peng LS, Penichet ML, Dela Cruz JS, Sampogna SL, Morrison SL. Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3). Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 21: 709-20. PMID 11576465 DOI: 10.1089/107999001753124444  1
2001 Penichet ML, Dela Cruz JS, Shin SU, Morrison SL. A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors. Human Antibodies. 10: 43-9. PMID 11455061 DOI: 10.3233/Hab-2000-10107  1
2001 Coloma MJ, Clift A, Wims L, Morrison SL. The role of carbohydrate in the assembly and function of polymeric IgG Molecular Immunology. 37: 1081-1090. PMID 11451414 DOI: 10.1016/S0161-5890(01)00024-4  1
2001 Zhang HF, Lu S, Morrison SL, Tomlinson S. Targeting of Functional Antibody-Decay-accelerating Factor Fusion Proteins to a Cell Surface Journal of Biological Chemistry. 276: 27290-27295. PMID 11352906 DOI: 10.1074/Jbc.M100436200  1
2001 Penichet ML, Dela Cruz JS, Challita-Eid PM, Rosenblatt JD, Morrison SL. A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity. Cancer Immunology, Immunotherapy : Cii. 49: 649-62. PMID 11258791 DOI: 10.1007/S002620000155  1
2001 Penichet ML, Morrison SL. Antibody-cytokine fusion proteins for the therapy of cancer. Journal of Immunological Methods. 248: 91-101. PMID 11223071 DOI: 10.1016/S0022-1759(00)00345-8  1
2000 Dela Cruz JS, Trinh KR, Morrison SL, Penichet ML. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity. Journal of Immunology (Baltimore, Md. : 1950). 165: 5112-21. PMID 11046042 DOI: 10.4049/Jimmunol.165.9.5112  1
2000 Trinh KR, Morrison SL. Site-specific and directional gene replacement mediated by Cre recombinase Journal of Immunological Methods. 244: 185-193. PMID 11033031 DOI: 10.1016/S0022-1759(00)00250-7  1
2000 Chan LA, Lyczak JB, Zhang K, Morrison SL, Saxon A. The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex. Molecular Immunology. 37: 241-52. PMID 10930631 DOI: 10.1016/S0161-5890(00)00042-0  0.52
2000 Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes Journal of Experimental Medicine. 191: 2171-2181. PMID 10859341 DOI: 10.1084/Jem.191.12.2171  1
2000 Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharmaceutical Research. 17: 266-74. PMID 10801214 DOI: 10.1023/A:1007592720793  1
1999 Yoo EM, Coloma MJ, Trinh KR, Nguyen TQ, Vuong LU, Morrison SL, Chintalacharuvu KR. Structural requirements for polymeric immunoglobulin assembly and association with J chain. The Journal of Biological Chemistry. 274: 33771-7. PMID 10559270 DOI: 10.1074/Jbc.274.47.33771  1
1999 Penichet ML, Kang YS, Pardridge WM, Morrison SL, Shin SU. An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: Initial applications in anti-HIV antisense drug delivery to the brain Journal of Immunology. 163: 4421-4426. PMID 10510383  1
1999 Peng LS, Penichet ML, Morrison SL. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity. Journal of Immunology (Baltimore, Md. : 1950). 163: 250-8. PMID 10384123  1
1999 Penichet ML, Challita PM, Shin SU, Sampogna SL, Rosenblatt JD, Morrison SL. In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice Laboratory Animal Science. 49: 179-188. PMID 10331548  1
1999 Chintalacharuvu KR, Morrison SL. Production and characterization of recombinant IgA Immunotechnology. 4: 165-174. PMID 10231086 DOI: 10.1016/S1380-2933(98)00012-8  1
1999 Chapman TL, You I, Joseph IM, Bjorkman PJ, Morrison SL, Raghavan M. Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. The Journal of Biological Chemistry. 274: 6911-9. PMID 10066744 DOI: 10.1074/Jbc.274.11.6911  1
1999 Bonagura VR, Kwong T, Kenny T, Robbins DL, Morrison SL. The specificity of synovial IgM rheumatoid factors (RF) for genetically engineered IgG antibodies is not affected by the method used to immortalize RF-producing B cells. Scandinavian Journal of Immunology. 49: 106-11. PMID 10023865 DOI: 10.1046/j.1365-3083.1999.00475.x  1
1999 Montaño RF, Morrison SL. A colorimetric-enzymatic microassay for the quantitation of antibody- dependent complement activation Journal of Immunological Methods. 222: 73-82. PMID 10022374 DOI: 10.1016/S0022-1759(98)00181-1  1
1999 Coloma MJ, Trinh RK, Martinez AR, Morrison SL. Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1→6) dextran antibody Journal of Immunology. 162: 2162-2170. PMID 9973491  1
1999 Zhang HF, Yu J, Bajwa E, Morrison SL, Tomlinson S. Targeting of functional antibody-CD59 fusion proteins to a cell surface Journal of Clinical Investigation. 103: 55-61. PMID 9884334 DOI: 10.1172/Jci4607  1
1998 Mohammed SM, Morrison S, Wims L, Trinh KR, Wildeman AG, Bonselaar J, Etches RJ. Deposition of genetically engineered human antibodies into the egg yolk of hens. Immunotechnology : An International Journal of Immunological Engineering. 4: 115-25. PMID 9853953 DOI: 10.1016/S1380-2933(98)00013-X  1
1998 Guan L, Wims LA, Kane RR, Smuckler MB, Morrison SL, Hawthorne MF. Homogeneous immunoconjugates for boron neutron-capture therapy: design, synthesis, and preliminary characterization. Proceedings of the National Academy of Sciences of the United States of America. 95: 13206-10. PMID 9789066 DOI: 10.1073/pnas.95.22.13206  1
1998 Challita-Eid PM, Abboud CN, Morrison SL, Penichet ML, Rosell KE, Poles T, Hilchey SP, Planelles V, Rosenblatt JD. A RANTES-antibody fusion protein retains antigen specificity and chemokine function Journal of Immunology. 161: 3729-3736. PMID 9759898  1
1998 Zuckier LS, Chang CJ, Scharff MD, Morrison SL. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life. Cancer Research. 58: 3905-8. PMID 9731501  1
1998 Penichet ML, Harvill ET, Morrison SL. An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity Journal of Interferon and Cytokine Research. 18: 597-607. PMID 9726441 DOI: 10.1089/Jir.1998.18.597  1
1998 Challita-Eid PM, Penichet ML, Shin SU, Poles T, Mosammaparast N, Mahmood K, Slamon DJ, Morrison SL, Rosenblatt JD. A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway Journal of Immunology. 160: 3419-3426. PMID 9531302  1
1998 Wright A, Morrison SL. Effect of C2-associated carbohydrate structure on Ig effector function: Studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells Journal of Immunology. 160: 3393-3402. PMID 9531299  1
1998 Chintalacharuvu KR, Morrison SL. Production of secretory immunoglobulin a in a single mammalian cell: Role of alpha chain domains in its assembly with J chain and secretory component Faseb Journal. 12.  1
1997 Sensel MG, Kane LM, Morrison SL. Amino acid differences in the n-terminus of C(h)2 influence the relative abilities of IgG2 and IgG3 to activate complement Molecular Immunology. 34: 1019-1029. PMID 9488053 DOI: 10.1016/S0161-5890(97)00112-0  1
1997 Penichet ML, Harvill ET, Morrison SL. Antibody-IL-2 fusion proteins: A novel strategy for immune potentiation Human Antibodies. 8: 106-118. PMID 9322080 DOI: 10.3233/Hab-1997-8301  1
1997 Chintalacharuvu KR, Morrison SL. Production of secretory immunoglobulin A by a single mammalian cell Proceedings of the National Academy of Sciences of the United States of America. 94: 6364-6368. PMID 9177223 DOI: 10.1073/Pnas.94.12.6364  1
1997 Coloma MJ, Morrison SL. Design and production of novel tetravalent bispecific antibodies Nature Biotechnology. 15: 159-163. PMID 9035142 DOI: 10.1038/Nbt0297-159  1
1997 Wright A, Morrison SL. Effect of glycosylation on antibody function: Implications for genetic engineering Trends in Biotechnology. 15: 26-32. PMID 9032990 DOI: 10.1016/S0167-7799(96)10062-7  1
1997 Sensel MG, Josefina Coloma M, Harvill ET, Shin SU, Smith RIF, Morrison SL. Engineering novel antibody molecules Chemical Immunology. 65: 129-158. PMID 9018876 DOI: 10.1159/000425636  1
1997 Coloma MJ, Trinh KR, Wims LA, Morrison SL. The Hinge as a Spacer Contributes to Covalent Assembly and Is Required for Function of IgG Journal of Immunology. 158: 733-740. PMID 8992989  1
1997 Chuang PD, Morrison SL. Elimination of N-Linked Glycosylation Sites from the Human IgA1 Constant Region: Effects on Structure and Function Journal of Immunology. 158: 724-732. PMID 8992988  1
1996 Harvill ET, Morrison L S. An IgG3-IL-2 fusion protein has higher affinity than hrIL-2 for the IL-2R alpha subunit: Real time measurement of ligand binding Molecular Immunology. 33: 1007-1014. PMID 8960125 DOI: 10.1016/S0161-5890(96)00027-2  0.88
1996 Chintalacharuvu KR, Morrison SL. Residues Critical for H-L Disulfide Bond Formation in Human IgA1 and IgA2 Journal of Immunology. 157: 3443-3449. PMID 8871643  1
1996 Harvill ET, Fleming JM, Morrison SL. In Vivo Properties of an IgG3-IL-2 Fusion Protein: A General Strategy for Immune Potentiation 1 Journal of Immunology. 157: 3165-3170. PMID 8816429  1
1996 Lyczak JB, Zhang K, Saxon A, Morrison SL. Expression of novel secreted isoforms of human immunoglobulin E proteins Journal of Biological Chemistry. 271: 3428-3436. PMID 8631944 DOI: 10.1074/Jbc.271.7.3428  1
1995 Harvill ET, Morrison SL. An IgG3-IL2 fusion protein activates complement, binds FcγRI, generates LAK activity and shows enhanced binding to the high affinity IL-2R Immunotechnology. 1: 95-105. PMID 9373338 DOI: 10.1016/1380-2933(95)00009-7  1
1995 Smith RIF, Coloma MJ, Morrison SL. Addition of a μ-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4 Journal of Immunology. 154: 2226-2236. PMID 7868896  1
1995 Poon PH, Morrison SL, Schumaker VN. Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b. The Journal of Biological Chemistry. 270: 8571-7. PMID 7721758 DOI: 10.1074/Jbc.270.15.8571  1
1995 Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry. 34: 14649-57. PMID 7578107 DOI: 10.1021/Bi00045A005  1
1995 Endo T, Wright A, Morrison SL, Kobata A. Glycosylation of the variable region of immunoglobulin G-site specific maturation of the sugar chains Molecular Immunology. 32: 931-940. PMID 7476998 DOI: 10.1016/0161-5890(95)00078-S  1
1995 Morrison SL, Shin SU. Genetically engineered antibodies and their application to brain delivery Advanced Drug Delivery Reviews. 15: 147-175. DOI: 10.1016/0169-409X(95)00008-U  1
1995 Chintalacharuvu KR, Morrison SL. Chimeric antibodies: Production and applications Methods: a Companion to Methods in Enzymology. 8: 73-82. DOI: 10.1006/Meth.1995.9999  1
1994 Chou CL, Morrison SL. Intron sequences determine the expression of kappa light chain genes Molecular Immunology. 31: 99-107. PMID 8309481 DOI: 10.1016/0161-5890(94)90082-5  1
1994 Zuckier LS, Georgescu L, Chang CJ, Scharff MD, Morrison SL. The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer. 73: 794-9. PMID 8306262 DOI: 10.1002/1097-0142(19940201)73:3+<794::Aid-Cncr2820731308>3.0.Co;2-A  1
1994 Chintalacharuvu KR, Raines M, Morrison SL. Divergence of human α-chain constant region gene sequences: A novel recombinant α2 gene Journal of Immunology. 152: 5299-5304. PMID 8189047  1
1994 Morrison SL. Success in specification Nature. 368: 812-813. PMID 8159237 DOI: 10.1038/368812A0  1
1994 Shin SU, Friden P, Moran M, Morrison SL. Functional properties of antibody insulin-like growth factor fusion proteins Journal of Biological Chemistry. 269: 4979-4985. PMID 8106473  1
1994 Wright A, Morrison SL. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1 Journal of Experimental Medicine. 180: 1087-1096. PMID 8064227 DOI: 10.1084/Jem.180.3.1087  1
1994 Phillips ML, Tao MH, Morrison SL, Schumaker VN. Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization. Molecular Immunology. 31: 1201-10. PMID 7935507 DOI: 10.1016/0161-5890(94)90034-5  1
1994 Lyczak JB, Morrison SL. Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein Archives of Virology. 139: 189-196. PMID 7826209 DOI: 10.1007/BF01309464  1
1994 Smith RIF, Morrison SL. Recombinant polymerie IgG: An approach to engineering more potent antibodies Bio/Technology. 12: 683-688. PMID 7764912 DOI: 10.1038/Nbt0794-683  1
1994 He X, Archer GE, Wikstrand CJ, Morrison SL, Zalutsky MR, Bigner DD, Batra SK. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin Journal of Neuroimmunology. 52: 127-137. PMID 7518471 DOI: 10.1016/0165-5728(94)90106-6  1
1994 Morrison SL, Smith RIF, Wright A. Structural determinants of human IgG function Immunologist. 2: 119-124.  1
1993 Chou CL, Morrison SL. A common sequence motif near nonhomologous recombination breakpoints involving Ig sequences Journal of Immunology. 150: 5350-5360. PMID 8515063  1
1993 Chou CL, Morrison SL. An insertion-deletion event in murine immunoglobulin kappa gene resembles mutations at heavy-chain disease loci Somatic Cell and Molecular Genetics. 19: 131-139. PMID 8511672 DOI: 10.1007/Bf01233529  1
1993 Shin SU, Wright A, Morrison SL. Hybrid antibodies International Reviews of Immunology. 10: 177-186. PMID 8360584 DOI: 10.3109/08830189309061694  1
1993 Tao MH, Smith RIF, Morrison SL. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation Journal of Experimental Medicine. 178: 661-667. PMID 8340761 DOI: 10.1084/Jem.178.2.661  1
1993 Hamilton RG, Morrison SL. Epitope mapping of human immunoglobulin-specific murine monoclonal antibodies with domain-switched, deleted and point-mutated chimeric antibodies Journal of Immunological Methods. 158: 107-122. PMID 7679128 DOI: 10.1016/0022-1759(93)90263-7  1
1993 Wright A, Morrison SL. Antibody variable region glycosylation: biochemical and clinical effects Springer Seminars in Immunopathology. 15: 259-273. PMID 7504841 DOI: 10.1007/Bf00201106  1
1992 Coloma MJ, Hastings A, Wims LA, Morrison SL. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction Journal of Immunological Methods. 152: 89-104. PMID 1640112 DOI: 10.1016/0022-1759(92)90092-8  1
1992 Morrison SL. In vitro antibodies: Strategies for production and application Annual Review of Immunology. 10: 239-265. PMID 1590987 DOI: 10.1146/Annurev.Iy.10.040192.001323  1
1992 Bonagura VR, Artandi SE, Agostino N, Tao MH, Morrison SL. Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies. Dna and Cell Biology. 11: 245-52. PMID 1567557 DOI: 10.1089/Dna.1992.11.245  1
1992 Ward SB, Morrison SL. Sequence of the γ2b membrane 3' untranslated region: Polya site determination and comparison to the γ2a membrane 3' untranslated region Molecular Immunology. 29: 279-285. PMID 1542303 DOI: 10.1016/0161-5890(92)90110-J  1
1992 Wright A, Shin SU, Morrison SL. Genetically engineered antibodies: Progress and prospects Critical Reviews in Immunology. 12: 125-168. PMID 1476621  1
1992 Braun J, Saxon A, Wall R, Morrison SL. The second century of the antibody - Molecular perspectives in regulation, pathophysiology, and therapeutic applications Western Journal of Medicine. 157: 158-168. PMID 1441467  1
1992 Artandi SE, Calame KL, Morrison SL, Bonagura VR. Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3. Proceedings of the National Academy of Sciences of the United States of America. 89: 94-8. PMID 1370358 DOI: 10.1073/Pnas.89.1.94  1
1992 Shin SU, Wright A, Bonagura V, Morrison SL. Genetically-engineered antibodies : Tools for the study of diverse properties of the antibody molecule Immunological Reviews. 86-107. PMID 1286874 DOI: 10.1111/J.1600-065X.1992.Tb01522.X  1
1991 Tao MH, Canfield SM, Morrison SL. The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain Journal of Experimental Medicine. 173: 1025-1028. PMID 2007852  1
1991 Canfield SM, Morrison SL. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region Journal of Experimental Medicine. 173: 1483-1491. PMID 1827828  1
1991 Harrold S, Genovese C, Kobrin B, Morrison SL, Milcarek C. A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Analytical Biochemistry. 198: 19-29. PMID 1789423 DOI: 10.1016/0003-2697(91)90500-S  1
1991 Anderson MT, Wims LA, Morrison SL. The pllaswoacfloma J558B lacks constitutivdy active NF-×B and is deficient in early response gene activation Nucleic Acids Research. 19: 7235-7241. PMID 1766879 DOI: 10.1093/Nar/19.25.7235  1
1991 Ward SB, Morrison SL. Spontaneous deletions in lg heavy chain genes: Flanking sequences influence splice site selection Nucleic Acids Research. 19: 6475-6480. PMID 1754385 DOI: 10.1093/Nar/19.23.6475  1
1991 Wright A, Tao MH, Kabat EA, Morrison SL. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. The Embo Journal. 10: 2717-23. PMID 1717254 DOI: 10.1002/J.1460-2075.1991.Tb07819.X  1
1990 Tan LK, Shopes RJ, Oi VT, Morrison SL. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins Proceedings of the National Academy of Sciences of the United States of America. 87: 162-166. PMID 2296577 DOI: 10.1073/Pnas.87.1.162  1
1990 Morrison SL, Schlom J. Recombinant chimeric monoclonal antibodies Important Advances in Oncology. 3-18. PMID 2182522  1
1990 Klein BY, Morrison SL. Expression of genes containing the IgH enhancer in non-lymphoid cells Molecular Immunology. 27: 713-722. PMID 2119478 DOI: 10.1016/0161-5890(90)90080-J  1
1990 Shin SU, Morrison SL. Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: Potential applications for cellular targeting Proceedings of the National Academy of Sciences of the United States of America. 87: 5322-5326. PMID 2115168 DOI: 10.1073/Pnas.87.14.5322  1
1990 Black A, Kabat EA, Morrison SL. Rabbit antisera to the variable region domains of an anti-alpha(1----6) dextran using E. coli-produced VL and VH fusion proteins as immunogens. Journal of Immunological Methods. 127: 123-30. PMID 1690781 DOI: 10.1016/0022-1759(90)90348-Y  1
1989 Brown SL, Morrison SL. Developmental regulation of membrane and secretory Ig γ2b mRNA Journal of Immunology. 142: 2072-2080. PMID 2921524  1
1989 Morrison SL, Ol VT. Genetically engineered antibody molecules Advances in Immunology. 44: 65-92. PMID 2646862 DOI: 10.1016/S0065-2776(08)60640-9  1
1989 Brown SL, Morrison SL. Regulation of the production of secretory and membrane immunoglobulin during lymphocyte development Clinical Immunology and Immunopathology. 50: 155-170. PMID 2644062 DOI: 10.1016/0090-1229(89)90125-6  1
1989 Morrison SL. Genetically engineered (Chimeric) antibodies Hospital Practice. 24: 65-80. PMID 2551912 DOI: 10.1080/21548331.1989.11703799  1
1989 Shin SU, Morrison SL. Production and properties of chimeric antibody molecules Methods in Enzymology. 178: 459-476. PMID 2513467 DOI: 10.1016/0076-6879(89)78034-4  1
1989 Tao MH, Morrison SL. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region Journal of Immunology. 143: 2595-2601. PMID 2507634  1
1989 Wallick SC, Kabat EA, Morrison SL. The effect of isotype and the J kappa region on antigen binding and idiotype expression by antibodies binding alpha (1----6) dextran. Journal of Immunology (Baltimore, Md. : 1950). 142: 1235-44. PMID 2464641  1
1988 Morrison SL, Wims LA, Oi VT. Genetically engineered antibody molecules: New tools for cancer therapy Cancer Investigation. 6: 185-192. PMID 3288296 DOI: 10.3109/07357908809077046  1
1988 Morrison SL. New approaches to the production of monoclonal antibodies Science. 239. PMID 3277278  1
1988 Gregor PD, Morrison SL. The IgA myeloma W3129 contains a deletion in CH3 which prevents the formation of the membrane form of heavy chain mRNA Molecular Immunology. 25: 495-503. PMID 3137459 DOI: 10.1016/0161-5890(88)90170-8  1
1988 Kobrin B, Glass K, Morrison SL, Milcarek C. An immunoglobulin heavy chain gene deletion at direct repeats: Nucleotide sequence and effect on mrna accumulation Molecular Immunology. 25: 181-187. PMID 3131666 DOI: 10.1016/0161-5890(88)90066-1  1
1988 Wallick SC, Kabat EA, Morrison SL. Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen. The Journal of Experimental Medicine. 168: 1099-109. PMID 2459288 DOI: 10.1084/Jem.168.3.1099  1
1988 Tan LK, Morrison SL. Antibody structure and antibody engineering Advanced Drug Delivery Reviews. 2: 129-142. DOI: 10.1016/0169-409X(88)90030-0  1
1987 Morrison SL, Wims L, Wallick S, Tan L, Oi VT. Genetically engineered antibody molecules and their application Annals of the New York Academy of Sciences. 507: 187-198. PMID 3327412  1
1986 Morrison SL, Wims LA, Kobrin B, Oi VT. Production of novel immunoglobulin molecules by gene transfection Mount Sinai Journal of Medicine. 53: 175-180. PMID 3084959  1
1986 Gregor PD, Kobrin BJ, Milcarek C, Morrison SL. Sequences 3' of immunoglobulin heavy chain genes influence their expression Immunological Reviews. 89: 31-48. PMID 3081431 DOI: 10.1111/J.1600-065X.1986.Tb01471.X  1
1986 Gregor PD, Morrison SL. Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products Molecular and Cellular Biology. 6: 1903-1916. PMID 3023910  1
1986 Kobrin BJ, Milcarek C, Morrison SL. Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane specific IgG2b mRNA in myeloma cells Molecular and Cellular Biology. 6: 1687-1697. PMID 2878362 DOI: 10.1128/Mcb.6.5.1687  1
1985 Wims LA, Sharon J, Newman B, Kabat EA, Morrison SL. C57BL/6 x BALB/c hybridomas produce IgA which assembles into molecules with covalent bonds between heavy chains (H) and light chains (L), and into molecules lacking covalent bonds between H and L. Molecular Immunology. 22: 1379-86. PMID 3938526 DOI: 10.1016/0161-5890(85)90060-4  1
1985 Tan LK, Oi VT, Morrison SL. A human-mouse chimeric immunoglobulin gene with a human variable region is expressed in mouse myeloma cells Journal of Immunology. 135: 3564-3567. PMID 3930609  1
1985 Morrison SL. Transfectomas provide novel chimeric antibodies Science. 229: 1202-1207. PMID 3929380  1
1985 Sikder SK, Kabat EA, Morrison SL. Alternative splicing patterns in an aberrantly rearranged immunoglobulin kappa-light-chain gene. Proceedings of the National Academy of Sciences of the United States of America. 82: 4045-9. PMID 2408274 DOI: 10.1073/Pnas.82.12.4045  1
1985 Kobrin BJ, Milcarek CA, Morrison SL. Regulation and expression of secreted verus membrane immunoglobulin MRNA Federation Proceedings. 44.  1
1984 Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains Proceedings of the National Academy of Sciences of the United States of America. 81: 6851-6855. PMID 6436822  1
1984 Morrison SL, Oi VT. Transfer and expression of immunoglobulin genes Annual Review of Immunology. 2: 239-256. PMID 6100473 DOI: 10.1146/Annurev.Iy.02.040184.001323  1
1984 Brandt CR, Morrison SL, Birshtein BK, Milcarek C. Loss of a consensus splice signal in a mutant immunoglobulin gene eliminates the CH1 domain exon from the mRNA Molecular and Cellular Biology. 4: 1270-1277. PMID 6095057 DOI: 10.1128/MCB.4.7.1270  1
1984 Morrison SL. Immunoglobulin: Heavy chain deletions. A commentary Journal of Molecular and Cellular Immunology. 1: 291.  1
1983 Gillies SD, Morrison SL, Oi VT, Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell. 33: 717-28. PMID 6409417 DOI: 10.1016/0092-8674(83)90014-4  1
1983 Oi VT, Morrison SL, Herzenberg LA, Berg P. Immunoglobulin gene expression in transformed lymphoid cells Proceedings of the National Academy of Sciences of the United States of America. 80: 825-829. PMID 6402777 DOI: 10.1073/Pnas.80.3.825  1
1982 Berger CL, Morrison S, Chu A, Patterson J, Estabrook A, Takezaki S, Sharon J, Warburton D, Irigoyen O, Edelson RL. Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. The Journal of Clinical Investigation. 70: 1205-15. PMID 6217214 DOI: 10.1172/Jci110719  1
1982 Matsuuchi L, Morrison SL. Isolation and characterization of a variant of mouse plasmacytoma J558 synthesizing a 110,000-dalton immunoglobulin heavy chain and of secondary variants synthesizing either a 55,000-dalton or an 80,000-dalton immunoglobulin heavy chain: Possible implications Molecular and Cellular Biology. 2: 1134-1144. PMID 6184610  1
1982 Sharon J, Kabat EA, Morrison SL. Association constants of hybridoma antibodies specific for alpha (1 leads to 6) linked dextran determined by affinity electrophoresis. Molecular Immunology. 19: 389-97. PMID 6178962 DOI: 10.1016/0161-5890(82)90204-8  1
1982 Sharon J, Kabat EA, Morrison SL. Immunochemical characterization of binding sites of hybridoma antibodies specific for alpha (1 leads to 6) linked dextran. Molecular Immunology. 19: 375-88. PMID 6178961 DOI: 10.1016/0161-5890(82)90203-6  1
1982 Sharon J, D'Hoostelaere L, Potter M, Kabat EA, Morrison SL. A cross-reactive idiotype, QUPC52 IdX, present on most but not all anti-alpha (1 replaced by 6) dextran-specific IgM and IgA hybridoma antibodies with combining sites of different sizes. Journal of Immunology (Baltimore, Md. : 1950). 128: 498-500. PMID 6172490  1
1981 Zack DJ, Morrison SL, Cook WD, Dackowski W, Scharff MD. Somatically generated mouse myeloma variants synthesizing IgA half-molecules. The Journal of Experimental Medicine. 154: 1554-69. PMID 7299348 DOI: 10.1084/Jem.154.5.1554  1
1981 Morrison SL, Scharff MD. Mutational events in mouse myeloma cells. Critical Reviews in Immunology. 3: 1-22. PMID 6807601  1
1981 Matsuuchi L, Sharon J, Morrison SL. An analysis of heavy chain glycopeptides of hybridoma antibodies: Correlation between antibody specificity and sialic acid content Journal of Immunology. 127: 2188-2190. PMID 6795268  1
1981 Wims LA, Morrison SL. ICR-191 and ethyl methanesulfonate induced mutagenesis at the immunoglobulin locus in the Y5606 cultured myeloma cell line Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 81: 215-228. PMID 6787418 DOI: 10.1016/0027-5107(81)90036-1  1
1981 Vora S, Wims LA, Durham S, Morrison SL. Production and characterization of monoclonal antibodies to the subunits of human phosphofructokinase: New tools for the immunochemical and genetic analyses of isozymes Blood. 58: 823-829. PMID 6456026  1
1981 Dackowski W, Morrison SL. Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases Proceedings of the National Academy of Sciences of the United States of America. 78: 7091-7095. PMID 6273910 DOI: 10.1073/Pnas.78.11.7091  1
1981 Monk RJ, Morrison SL, Milcarek C. Heavy-chain mutants derived from γ2b mouse myeloma: Characterization of heavy-chain messenger ribonucleic acid, proteins, and secretion in deletion mutants and messenger ribonucleic acid in γ2a mutant progeny Biochemistry. 20: 2330-2339. PMID 6263311 DOI: 10.1021/Bi00511A040  1
1981 Sharon J, Kabat EA, Morrison SL. Studies on mouse hybridomas secreting IgM or IgA antibodies to alpha(1 to 6)-linked dextran. Molecular Immunology. 18: 831-46. PMID 6175897 DOI: 10.1016/0161-5890(81)90005-5  1
1981 Matsuuchi L, Wims LA, Morrison SL. A variant of the dextran-binding mouse plasmacytoma J558 with altered glycosylation of its heavy chain and decreased reactivity with polymeric dextran Biochemistry. 20: 4827-4835. PMID 6170317 DOI: 10.1021/Bi00520A004  1
1980 Sharon J, Morrison SL, Rabat EA. Formation of hybridoma clones in soft agarose: Effect of pH and of medium Somatic Cell Genetics. 6: 435-441. PMID 7190739 DOI: 10.1007/BF01542794  1
1979 Sharon J, Morrison SL, Kabat EA. Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies Proceedings of the National Academy of Sciences of the United States of America. 76: 1420-1424. PMID 286325 DOI: 10.1073/Pnas.76.3.1420  1
1979 Morrison SL, Scharff MD. A mouse myeloma variant with a defect in light chain synthesis. European Journal of Immunology. 9: 461-5. PMID 115696 DOI: 10.1002/Eji.1830090609  1
1979 Morrison SL. Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins Journal of Immunology. 123: 793-800. PMID 110881  1
1978 Matsuuchi L, Morrison SL. Estimation of antibodies specific for dextran Journal of Immunology. 121: 962-965. PMID 99480  1
1978 Morrison SL. Murine heavy chain disease European Journal of Immunology. 8: 194-199. PMID 95958  1
1977 Margulies DH, Cieplinski W, Dharmgrongartama B, Gefter ML, Morrison SL, Kelly T, Scharff MD. Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harbor Symposia On Quantitative Biology. 41: 781-91. PMID 408077 DOI: 10.1101/Sqb.1977.041.01.089  1
1975 Morrison SL, Scharff MD. Heavy chain-producing variants of a mouse myeloma cell line. Journal of Immunology (Baltimore, Md. : 1950). 114: 655-9. PMID 804509  1
1972 Terres G, Morrison SL, Habicht GS, Stoner RD. Appearance of an early "primed state" in mice following the concomitant injections of antigen and specific antiserum Journal of Immunology. 108: 1473-1481. PMID 5031322  1
1972 Morrison SL, Koshland ME. Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure) Proceedings of the National Academy of Sciences of the United States of America. 69: 124-128. PMID 4109595 DOI: 10.1073/Pnas.69.1.124  1
1968 Terres G, Morrison SL, Habicht GS. A Quantitative Difference in the Immune Response between Male and Female Mice Proceedings of the Society For Experimental Biology and Medicine. 127: 664-667. PMID 5651115 DOI: 10.3181/00379727-127-32768  1
1967 Terres G, Morrison SL. Enhanced immunologic sensitization of mice by the simultaneous injection of antigen and specific antiserum. 3. The role of antigen in controlling the immune response elicited with immune complexes Journal of Immunology. 98: 584-592. PMID 4164059  1
1966 Morrison SL, Terres G. Enhanced immunologic sensitization of mice by the simultaneous injection of antigen and specific antiserum. II. Effect of varying the antigen-antibody ratio and the amount of immune complex injected Journal of Immunology. 96: 901-905. PMID 5913760  1
1965 MORRISON SL, TERRES G. IMMUNE DEGRADATION IN PASSIVELY SENSITIZED MICE. II. DEGRADATION OF Journal of Immunology (Baltimore, Md. : 1950). 94: 667-673. PMID 14296285  1
Show low-probability matches.